DIN 02299925 — ATRIANCE 5 MG
ATRIANCE is a solution of Nelarabine marketed by SANDOZ CANADA INCORPORATED. The full Nelarabine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02299925
- Brand name
- ATRIANCE
- Active ingredient
- Nelarabine
- Strength
- 5 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Antineoplastic agent (purine nucleoside analogue prodrug)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.